NCT05262530 2026-04-08Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid TumorsBioNTech SEPhase 1/2 Terminated73 enrolled
NCT05023655 2026-03-17Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A MutationPrisma Health-UpstatePhase 2 Terminated20 enrolled
NCT05100251 2026-02-17Clinical Trial of WBC100 on Advanced Solid TumorZhejiang UniversityPhase 1 Terminated68 enrolled
NCT07108140 2026-01-22Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid TumorsTCRCure Biopharma Ltd.Phase EARLY_PHASE1 Terminated5 enrolled
NCT04617054 2026-01-21Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene FusionNuvation Bio Inc.Phase 2 Terminated14 enrolled